MicroRNAs (miRs) are small non-coding molecules, considered excellent clinical biomarkers; however, they are more unstable in circulation than other classes of nucleic acids. The intricate host-virus interaction, by modulating the miR pathway, generally promotes viral persistence by decreasing immune detection. For data analysis, studies were selected from the NCBI, VHL, LILACS, and SciELO databases that discuss the pathogenesis orchestrated by oncogenic miRs in HTLV-1, HBV, and HCV infections. As a complementary strategy, experimental articles were also selected to serve as the basis for presenting the results. A total of 180 articles were found, and the inclusion criteria encompassed experimental studies, controlled trials, and literature reviews. Among these, six experimental articles were selected to comprise the results of this work, as they met the established criteria. This review elucidated the molecular mechanisms associated with HTLV-1, HBV, and HCV infection. The results show that several miRs are associated with leukemic transformation in the ATL group, reinforcing the potential involvement of these molecules in the pathogenesis of HTLV-1–associated ATL. Additionally, the regulation of these molecules is altered in HBV and HCV infections, in which these hepatotropic viruses deregulate pathways such as NF-κB, PI3K/AKT/mTOR, TP53, and WNT through various mechanisms, leading to uncontrolled hepatocarcinogenesis.